Controlling hunger between meals is a challenge for many individuals. This manuscript comprises 2 sequential clinical trials investigating the effects of psyllium (Metamucil) on satiety, both using a randomized, double-blind, placebo-controlled cross-over design. The first study determined the effects of 3.4 g, 6.8 g, and 10.2 g of psyllium taken before breakfast and lunch for 3 days. The second study determined the effects of 6.8 g (taken before breakfast and lunch on Days 1 and 2 and before breakfast on Day 3) on the satiety of participants receiving an energy restricted meal in the morning (breakfast) for 3 days. Efficacy endpoints were mean inter-meal hunger, desire to eat, and Satiety Labeled Intensity Magnitude Visual Analog Scale scores. In Study 1, all 3 psyllium doses resulted in directional or statistically significant mean reductions in hunger and desire to eat, and increased fullness between meals compared to placebo, with both higher doses better than placebo or 3.4 g. The 6.8 g dose provided more consistent (p 0.013) satiety benefits versus placebo. In Study 2, satiety was assessed similarly to Study 1. A significant (p 0.004) decrease in the 3-day mean hunger and desire to eat, as well as an increase in fullness for psyllium relative to placebo was observed. Most adverse events were mild gastrointestinal symptoms and were similar for psyllium compared to placebo. These results indicate that psyllium supplementation contributes to greater fullness and less hunger between meals.
Introduction
A common difficulty faced by those attempting to change their habitual eating pattern to moderate energy intake or body weight is to control appetite throughout the day (Rigaud, Paycha, Meulemans, Merrouche, & Mignon, 1998) . This is challenging, because appetite is influenced by a multitude of biological, behavioral, and environmental stimuli. (Bergmann, Chassany, Petit, Triki, Caulin, & Segrestaa, 1992) . It is well established that more energy-dense foods (high energy/g) often have lower satiety index scores and produce shorter inter-meal intervals than foods with low energy density (Blundell, Green, & Burley, 1994; Hylander & Rӧssner, 1983) . Alternatively, bulky and well-hydrated foods that are high in protein and fiber often have higher satiety index scores and produce longer inter-meal intervals with low hunger.
Although being satiated after a meal is no guarantee of lower total daily energy intake, hunger plays an important role when adhering to diets that aim to control energy intake (Burton, Smit, & Lightowler, 2007; Das et al. 2009; Gilhooly et al. 2008; Martin, O'Neil, & Pawlow, 2006; Wing et al. 2008) . Furthermore, complex dietary regimens are not likely to be well accepted by most people trying to maintain a sense of satiety while reducing their energy intake. Energy restriction programs could therefore be improved through the use of familiar products that enhance satiety such as a cereal enriched with fiber (Gilhooly et al. 2008) .
Fibers often promote higher satiety when compared with digestible complex carbohydrates and simple sugars. There are a large number of dietary fiber technologies reported in the literature and commercially available to replace energy-rich foods and for management of energy intake. Others have calculated that an additional 14 g/day of dietary fiber provided with meals for more than 2 days could result in up to a 10% decrease in daily energy intake (Howarth, Saltzman, & Roberts, 2001) . Thus, it is reasonable to hypothesize that the use of dietary soluble viscous fiber may be a useful tool for long-term healthy weight management (De Graaf, Blom, Smeets, & Stafleu, 2004; Hoad et al. 2004; Lyon & Kacinik, 2012; Marciani et al. 2000) .
Dietary soluble viscous fiber such as psyllium can slow gastric emptying and decrease the speed of absorption of fat and glucose exposing more distal parts of the small intestine to these energyyielding nutrients leading to a prolonged sense of fullness (Bergmann et al. 1992; Delargy, O'Sullivan, Fletcher, & Blundell, 1997; Hylander & Rossner, 1983; Rigaud et al., 1998; Turnbull & Thomas, 1995; Wanders et al. 2011) .
The majority of the research to date has demonstrated that consumption of psyllium, a gel forming non-fermentable viscous soluble fiber can reduce the risks of metabolic conditions by improving glucose levels and insulin response, as well as lipid profile in humans (McRorie, 2015) . There are several randomized, well-controlled clinical studies that assessed doses of 6e15 g/day (most studies at 10 g/day) psyllium in cardiometabolic conditions (McRorie, 2015) . These studies show that the cholesterol lowering effects of psyllium range from À2% to À20% for total cholesterol, and À6% to À24% for LDL-cholesterol versus placebo (Anderson, Floore, Geil, Spencer, & Balm, 1991; Cicero, Derosa, Bove, Imola, & Borghi, Gaddi, 2010; McRorie, 2015) . Psyllium supplementation can indeed reduce the risks of metabolic conditions by improving glucose levels and insulin response, as well as lipid profile in humans (McRorie, 2015) .
A previous study using ultrasound with obese patients, documented that psyllium moderately but significantly delays gastric emptying when provided with a solid meal (Bergmann et al. 1992) . Furthermore, the changes in gastric emptying were associated with a delayed appearance of hunger assessed by visual analog scale (VAS). Although this was a single meal study the authors proposed that dietary supplementation with psyllium fiber could be used to control satiety following repeated meals. These results and further clinical evidence of a post-meal satiety effect for psyllium (Bergmann et al., 1992; Delargy et al., 1997; Hylander & Rossner, 1983; Rigaud et al., 1998; Salas-Salvad o et al., 2008; Turnbull & Thomas, 1995) suggest that psyllium may be a useful dietary supplement to improve satiety and enhance adherence to energyrestricted dietary regimens.
Since previous studies had not investigated the effects of different doses of psyllium fiber and the reproducibility and persistence of the satiety effect across multiple meals, we undertook a systematic study plan to examine these variables. The studies described here show the results of 2 randomized, doubleblind, placebo-controlled cross-over studies evaluating dose response and multiple dosing effects of dietary psyllium fiber on the inter-meal satiety of healthy volunteers. The studies were designed to isolate as much as possible the effects of psyllium fiber on subjective sensations of satiety by fixing the intake of energy and the composition of food.
Material and methods
This manuscript comprises 2 sequential clinical trials (Study 1 and Study 2) investigating the effects of psyllium on satiety indices. These were randomized, double-blind, cross-over placebocontrolled studies. All individual were exposed to all treatments after 4e5 days of washout between periods.
The first was a study to determine the effects of 3 different doses of psyllium fiber (3.4 g, 6.8 g and 10.2 g) taken before a regular breakfast and lunch for 3 consecutive days. The second study determined the effects of 6.8 g of psyllium fiber given before meals also for 3 days (before breakfast and lunch on Days 1 and 2 and before breakfast on Day 3) on satiety of participants receiving energy restricted meals. The amount of food energy provided at the morning breakfast was lower in the second study in order to see if psyllium would increase satiety under a reduced energy condition.
Both studies were conducted in accordance with the International Conference on Harmonization (ICH) Harmonized Tripartite Guideline for Good Clinical Practice (GCP), 1997; the US Code of Federal Regulations (CFR) Title 21 parts 50, 56 and 312 and the guidelines stipulated in the Declaration of Helsinki. All procedures involving human subjects were approved by the Western IRB (Western Institutional Review Board, 3535 7th Avenue SW, Olympia, WA 98502). Before any study procedures were performed, all participants were informed in detail about the test products to be administered and the nature of the clinical investigation, including the risks and potential discomforts that could be expected. Written informed consent was obtained from all participants following basic elements as specified by the US CFR (Title 21, CFR 50.25 and 50.27) .
The studies were performed in a Phase I pharmacology unit (MedPace, Cincinnati, Ohio) and healthy participants were recruited from the MedPace database or by advertisement in local media. Participants were screened according to the inclusion/ exclusion criteria from À10 to À3 days (Screening Period, Visit 1) and signed informed consent before randomization. The main inclusion criteria were: men and women between 18 and 55 years of age that ate breakfast and lunch daily, had 1-2 bowel movements per day that are typically rated as 3, 4, or 5 on the Bristol Stool Form Scale (Lewis & Heaton, 1997) , generally healthy (medical history), body mass index (BMI) ! 18.5 but < 32 kg/m 2 , and willing to maintain their current lifestyle habits for the duration of the study (e.g., exercise and diet). Exclusion criteria included a history of cardiovascular, hepatic, renal, neurologic, hematologic/oncologic metabolic, endocrine, or gastrointestinal (GI) disease (e.g., peptic ulcer disease, gastroesophageal reflux disease, malabsorptive disease, inflammatory bowel disease, acrodermatitis enteropathica). Individuals with a history of an eating disorder; difficulty swallowing or history of GI surgery (except appendectomy) or had a significant psychiatric disorder (e.g., major depression, psychoses) or had a history of allergic reactions were excluded. Participants with a score <30 on a 100 mm VAS for palatability of study meals (Mattes, 2007) , or a score > 20 on the Eating Attitudes Test (EAT-26) (Garner, Olmsted, Bohr, & Garfinkel, 1982) were excluded. Eligible participants were randomly assigned to test product sequences on the first day of Test Period 1. Treatment periods were separated by a minimum 4-day washout during which no test product was administered.
2.1. Energy intake and satiety assessment instruments and procedures common to both studies Satiety was assessed subjectively by the participants using 3 different rating scales designed to measure their degree of hunger, desire to eat, and satiety. Participants were asked to complete these scales on each treatment day immediately before drinking the assigned test product prior to breakfast, immediately after breakfast, at half-hour intervals after breakfast until lunch, immediately after lunch, and at half-hour intervals after lunch until dinner. Participants were seated separately at a distance discouraging between subject interaction during meal consumption to avoid bias and interference with the assessment of satiety variables.
Participants had a single meal composition choice that varied by amount, as determined by individual energy requirements. Individual energy requirements in these studies were estimated with the participant at rest and confined to the study site facility prior to the first day of a Test Period and were based on weight, height, age, and gender using predictive equations for resting energy expenditure (REE) described by Mifflin, St Jeor, Hill, Scott, Daugherty, and Koh (1990) . Using these equations, participants were assigned a prescribed meal with composition of energy being the same for breakfast, lunch, and dinner; i.e., 50% carbohydrate, 34% fat, 16% protein, and approximately 9 g dietary fiber per day. For breakfast the menu consisted of waffles (with syrup and margarine), diced peaches in light syrup and scrambled eggs. For lunch the menu consisted of roasted turkey breast, white sandwich bread, iceberg lettuce, slice tomato, mayonnaise and mustard, potato chips and gelatin snacks. For dinner the subjects received a lean hamburger patty, sesame bun, leaf iceberg lettuce, a slice of tomato, mayonnaise and mustard, grapes, 0reos and vanilla pudding. The studies were designed to supply a relatively low level of fiber from the base diet (around 9 g/day) in order to minimize interaction of the additional viscous soluble psyllium fiber with other types of fibers in the diet. Psyllium at the various doses was added on top of the base diet raising the daily total from 9 g from the undigested food (placebo) up to a range of 19.2 g per day (10.2 g once a day plus fiber from food) to 22.6 g (psyllium 6.8 g twice a day plus fiber from food). The intent was to create a condition able to identify the independent effects of psyllium fiber on subjective satiety since psyllium is not a common dietary fiber. Since these were cross-over studies, all individuals were exposed for at least 3 treatment periods to a dietary fiber intake that was approximately within the range of the daily American average fiber intake (approximately 10e18 g per day) (King, Mainous, & Lambourne, 2012) .
Participants were instructed to fast overnight beginning at 12:00 a.m. before each test period visit and to adhere to all continuance criteria. In Study 1, participants were allowed to go home overnight and in Study 2, participants were housed overnight at the study facility for convenience.
Individual hunger and desire to eat sensations were assessed using a horizontal 100-mm VAS. The hunger scale was anchored on the left by the phrase "Not at all hungry" (score ¼ 0) and on the right by "As hungry as I have ever felt" (score ¼ 100). Participants placed a mark on the scale corresponding to their sensation of hunger. The numerical scores were not included on the blank form completed by the participants. Distances on the VAS were measured from the left border of the line in millimeters.
The VAS Desire to Eat Scale was constructed and implemented in a similar manner as the VAS hunger scale, though with the instructions "Rate your desire to eat". The anchor phrase on the left was "No desire at all" (score ¼ 0) and "As strong as I have ever felt" (score ¼ 100) on the right (Mattes, 2007) .
In addition to VAS hunger and desire to eat scales, the Satiety Labeled Intensity Magnitude (SLIM) Scale was used to assess perceived hunger/fullness following a meal (Cardelloa, Schutz, Lesher, & Merrill, 2005) . The scale uses 11 descriptive phrases placed along a vertical line scale anchored at the bottom by "Greatest imaginable hunger" (score ¼ À100) and at the top by "Greatest imaginable fullness" (score ¼ ±100). Participants placed a mark on the scale corresponding to their sensation of hunger/ fullness. The numerical scores were not included on the blank form completed by the participants. Distances on the scale were measured from the bottom border of the line in millimeters.
The order in which participants completed the 3 appetitive assessment scales was randomized. Each participant was assigned an assessment scale order and then followed that order for the duration of the study.
Blinding process (common to both studies)
Studies were conducted double-blind. The test products were similar with regard to taste and color but had slightly different consistencies for the different doses due to gelling of the psyllium when mixed with water. In Study 1, the participants were instructed to drink their assigned test product within a minute or as quickly as possible after mixing with water to minimize this subtle difference in consistency. Dosing was monitored and observed by study personnel blind to treatment code. An adequate level of isolation was maintained between the participants to avoid bias and interference with the assessment of satiety variables. The investigators were also blind to treatment codes.
Sample size
Sizing of the first study (Study1) was based, in part, on published statistical power calculations for VAS assessment of satiety (Flint, Raben, & Astrup, 2000) . Calculations were based on the average VAS satiety scores over the 4 h following a single meal. Assuming a mean VAS hunger or satiety scale treatment difference of 5 mm, completing the study with data from 25 evaluable participants was estimated to provide approximately 80% power at a significance level of 5%. Assuming a participant dropout rate of 15%, approximately 30 participants were targeted for enrollment.
Sizing for Study 2 was based on mean and residual variance estimates from the first Study VAS Hunger, SLIM, and VAS Desire to Eat 3-day averages. It was estimated that if 40 participants completed Study 2 there would be at least 90% power to detect treatment differences (6.8 g Psyllium vs. Placebo) comparable to those observed in Study 1 at a significance level of 5%.
Safety assessment (common to both studies)
Psyllium powder is an over-the-counter supplement considered safe for daily use. Several publications and regulatory bodies have assessed the safety of psyllium dietary fiber for daily consumption (Anderson et al., 2000; FDA Final Rule, 2007; Oliver, 2000) . Therefore, safety assessments for both studies included only routine laboratory data findings and the collection of adverse events (AEs) reported by the participants or observed by the investigator or study center personnel.
Test products administration (common to both studies)
Psyllium fiber (active) was supplied to the study site as Metamucil Orange Sugar Free Fiber Singles (Procter & Gamble, Cincinnati, OH). Placebo was made from excipients used in Metamucil Orange Sugar Free (maltodextrin, citric acid, natural and artificial orange flavors, aspartame and Yellow 6) to match appearance color and taste.
Study 1. Dose-finding protocol
The objective of this study was to determine the between-meal satiety effects of 3 different psyllium doses (3.4 g, 6.8 g, and 10.2 g) mixed with 295.7 mL of water before meals versus placebo in healthy participants over 3 consecutive days. This was a singlecenter, randomized, double-blind, placebo-controlled, 4-way cross-over study. Thirty healthy participants (19 men/11 women) were enrolled and 28 completed the study. The study population (mean ± SD) age and BMI were 34.1 ± 10.9 years and 24.8 ± 2.1 kg/ m 2 , respectively. Participants were served meals matched to estimate individual energy requirements at rest with breakfast comprising a substantial portion (average 28.4%) of daily energy intake.
For Study 1, all individuals received a single daily dose on their first day. The doses of 3.4 g and 6.8 g were given twice a day on the second and the third day. The dose of 10.2 g was given only once a day.
All individuals started the study receiving only 1 dose of psyllium fiber on the first day before breakfast. This was done to assess the potential impact of 3 single different doses on satiety responses.
The first day of dosing explored, therefore, the effect of different doses at breakfast only because all subjects received placebo with their lunch followed by the afternoon satiety assessment. On the second and third days, participants consumed their assigned test product (3.4 g and 6.8 g) before breakfast and lunch, however, the 10.2 g was given only once daily (psyllium before breakfast and placebo before lunch) to avoid potential side effects associated with a single large dose of soluble fiber. Satiety was assessed by selfratings of hunger and desire to eat on independent visual analog scales as well as hunger/fullness on the SLIM scale. Satiety assessments were made immediately before and after breakfast and then every 30 min for 4 h (10 morning assessments). Starting immediately after lunch, satiety assessments were made every 30 min for an additional 4 h, for a total of 19 assessments per day.
Study 2. Effects of psyllium on energy restricted meal protocol
After the completion and data analysis of the dose-response study described above, the effects of a single dose of psyllium sugar-free powder (6.8 g/295.7 mL of water) on satiety indices were evaluated. As the 6.8 g dose demonstrated the most consistent statistically significant satiety improvements in Study 1, the goal of this study was to confirm the efficacy of the 6.8 g psyllium dose before and after a lower energy-controlled breakfast. The trial also spanned 3 consecutive dosing days. The energy restriction in the breakfast simulated a less satiating breakfast commonly found in low energy diets. Therefore, it tested the ability of psyllium in curbing post-meal hunger under a presumably stronger hunger signal. This study was a randomized, double-blind, placebo controlled, 2-treatment, 3-period cross-over study with a different group of forty-four healthy participants (25 men/19 women, 40 completed the study). The study population was similar to the first study with the mean ± SD age and BMI being 35.3 ± 10.4 years and 26.3 ± 3.6 kg/m 2 , respectively. On each dosing day, participants consumed a breakfast providing energy equivalent to 15%e20% of their estimated individual resting energy expenditure but with the same proportions of carbohydrate, protein and fiber as in the first study. Satiety was assessed in a similar fashion to the first study with the same assessment scales. Satiety assessments were conducted at 30 min intervals following the breakfast. Satiety was not measured post-lunch.
Statistical analysis plan
The satiety data for each study were analyzed separately with a general linear mixed model for repeated measures, reflecting the fact that the study followed a crossover design. Each model included the post-baseline satiety score as the response variable with treatment and treatment period as fixed effects and baseline satiety score as a covariate. A separate model was fitted for each satiety measure (SLIM, VAS Hunger, VAS Desire to Eat) at each postbaseline measurement time. The significance level was set at 5% (two-sided).
In Study 1 separate models were fit to the post-breakfast and post-lunch data. For Study 2, the mean over the entire postbreakfast period was modeled, as well as the mean for the last 2 h preceding lunch. Each repeated measures model included Period and Treatment as fixed effects and Participant as a random effect. Baseline satiety score was also included as a covariate, where "Baseline" was defined as the Day 1 pre-breakfast satiety assessment.
Given the exploratory nature of Study 1, no attempt was made to control the experiment-wise false-positive error rate. However, in Study 2 a fixed-sequence testing procedure was used to maintain the overall false-positive error rate at 5%. Baseline satiety scores were assessed for balance across treatments with a general linear mixed model analysis similar to that described earlier, though in these models the baseline satiety score was the response variable.
Results

Participant disposition
Dispositions of participants in both studies are shown as a flow chart in Fig. 1 . Of the 30 participants randomized in Study 1, there were 28 who completed. In Study 2 a total of 44 participants were randomized and 40 completed.
Demographics and baseline satiety
Participant demographics and baseline satiety ratings are summarized in Tables 1 and 2 , respectively. There were no statistically significant differences between treatments with respect to any satiety endpoint in either study.
Treatment compliance (common to both studies)
Meal consumption and test product compliance (assessed by left-over weight) were similar across the test products. Participants in these studies ate essentially all the food presented, as they were instructed, insuring that the main independent variable was the effects of different doses of psyllium fiber on subjective sensations of satiety. A high percentage of meals (!97%; Study 1) and test product doses (!99%; Studies 1 and 2) were completely consumed. For Study 2, the average test product compliance rate met or exceeded 99% for both test products across all of the test periods.
Study 1 results
The overall mean post-meal satiety scores (i.e., scores averaged across all post-prandial measurement times and days) for the SLIM scale in Study 1 were significantly (p 0.031) higher (i.e., more fullness and less hunger) for psyllium 6.8 g and 10.2 g compared with placebo (Fig. 2) . The highest score post-breakfast was seen with Psyllium 10.2 g, which was only dosed once a day before breakfast.
A more granular summary of the post-meal SLIM results is provided in Fig. 3 . The mean fullness/hunger effect of psyllium fiber was sustained and relatively consistent through each betweenmeal period.
The VAS Desire to Eat Scale and the VAS Hunger Scale postbreakfast and post-lunch mean scores (i.e., scores averaged across all post-prandial measurement times and days) were lower significantly or directionally (p 0.025 and p 0.052, respectively) for all psyllium doses compared with placebo (Table 3 ). The overall pattern of improvement in satiety with the psyllium doses was similar after breakfast and lunch.
Considering all efficacy analyses performed in Study 1, the relationship between psyllium dose and satiety efficacy generally followed a trend of greatest efficacy with the 10.2 g followed by the 6.8 g dose, the 3.4 g dose, and then placebo. Although a clear separation between the 3.4 g low dose and the 2 higher doses (6.8 g and 10.2 g) did occur in the first period breakfast when all subjects received only a single dose before breakfast, a non-significant trend of separation occurred between the 2 higher doses. All doses can be compared at the post-breakfast satiety (first dose of the day) assessment since this is a cross-over study with washout between periods. Therefore, the post-breakfast assessment of the perceived satiety by the SLIM scale shows a clear trend towards dose-response in the first dosing period. The effect of psyllium on satiety for the doses 3.4 g and 6.8 g was generally greater post-breakfast than post-lunch. Of the 3 psyllium doses tested, the 6.8 g dose demonstrated the most consistent statistically significant improvements during the study.
The majority of the participants did not report any AEs on placebo (72.4%) or on psyllium 3.4 g (69.0%), 6.8 g (67.9%), and 10.2 g (55.2%). Abdominal distension and flatulence were more frequently reported in participants taking psyllium than in those taking placebo. There were no serious AEs, or withdrawals due to AEs occurring during the study. Most AEs were mild in severity and not different than previously known to occur with the oral supplementation of psyllium fiber and were therefore considered probably related to the test products.
Study 2 results
There was a statistically significant (p 0.008) decrease in the 3-day mean hunger and desire to eat ratings, as well as an increase in fullness with psyllium ingestion relative to placebo (Table 4) . Similar statistically significant (p 0.002) results were observed for the 3-day mean hunger, desire to eat, and fullness in the 2 h immediately prior to lunch. Psyllium fiber reduced between-meal hunger consistently over the 4.5 h post-breakfast period (Fig. 4) .
In Study 2, the mean satiety response to meal was of lesser magnitude than in Study 1. This difference was expected due to lower energy intake of the breakfast in Study 2 compared to Study 1. In Study 1, all individuals received a breakfast that comprised approximately 28.4% % of their required energy intake for the day according to REE. In Study 2 the participants received a smaller breakfast (20% of daily REE). Independently, the average hunger reducing effect of psyllium was equivalent to approximately 1/3 of the hunger reducing effect of breakfast under placebo in both studies (Fig. 5) .
The number and percentage of participants who reported AEs was similar for psyllium 6.8 g (3 [7.0%]) compared to placebo (3 [7.3%]). Gastrointestinal disorders (nausea and vomiting) and headache were the most commonly reported AEs in this study. There were no serious AEs, or withdrawals due to AEs occurring during the study. Most AEs were mild in severity and not different than previously known to occur with the oral supplementation of psyllium fiber and were therefore considered probably-related to the test products.
Discussion
This manuscript reports the findings of 2 independent studies investigating the ability of psyllium fiber supplementation to increase fullness and decrease measures of hunger and desire to eat in healthy volunteers.
A significant satiety effect of psyllium was observed in both studies. Study 1 investigated the satiety effects of 3 different doses and regimen of psyllium between meals (breakfast to lunch and lunch to dinner) over 3 days. The highest dose, 10.2 g was not statistically different from 6.8 g given before breakfast although it showed a tendency to cause a higher satiety effect than the 6.8 g dose. Both the 6.8 g and the single dose of 10.2 g doses were superior to the 3.4 g dose, suggesting that there is likely a doseresponse effect within the studied range. However, a larger sample population would be required to show clear differentiation between these 2 doses. Nevertheless, the study fulfilled the purpose of allowing the identification of an effective and practical dose of psyllium to achieve a significant satiety effect. In the first study, the satiety effect occurred following a breakfast containing energy equivalent to approximately 30% of the daily REE. In Study 2, the 6.8 g dose was used to verify whether the satiety effect of psyllium following consumption of a less satiating breakfast in a similar population of healthy individuals was reproducible. In Study 2, the participants consumed a breakfast with an energy content equivalent to only 15%e20% of the total daily REE. Therefore, as expected, the satiating effect of the breakfast itself (with placebo beverage) and the additional effect of psyllium were smaller in Study 2 than Study 1. Nevertheless, the overall effects of 6.8 g of psyllium twice a day on satiety were proportionally similar in both studies. The average hunger reducing effect of 6.8 g of psyllium fiber was equivalent to approximately 30% of the decrease in hunger in response to breakfast with placebo in both studies. It is reasonable to hypothesize that the effect of dietary psyllium fiber supplementation on satiety might be useful in weight management. A meta-analysis of 22 studies concluded that a 14 g increase in fiber intake is linked to a 10% reduction in energy intake and may have beneficial effects on long-term weight control (Howarth et al. 2001) . However, few studies have quantified the relationship of self-reported appetite to subsequent energy intake. A more recent review confirms a trend towards weight loss with high dietary fiber intake (Clark & Slavin, 2013) . Nevertheless the complexities involved in mechanisms of body weight control involves far more variables than just satiety and regarding psyllium it would need to be demonstrated through randomized trials addressing specifically the endpoint of weight loss. It has been suggested that a change of at least 10e15 mm in the VAS scale corresponds to a significant spontaneous decrease in energy intake in ad libitum situations where desire to eat plays a considerable role (Flint et al. 2000; Sadoul, Schuring, Mela, & Peters, 2014) . The findings of the studies in this report indicate that psyllium has a satiety effect but further investigation is necessary to determine its clinical relevance as a tool to promote decreased energy intake and weight control.
VAS satiety ratings alone do not always strongly correlate with food and energy intake (de Graaf, 1993; Stubbs et al., 2000) . Learned behaviors, environmental cues and satiety together strongly influence overall eating habits. Furthermore, VAS scales are subjective tools and are sensitive to individual interpretations. The satiety response to a meal is sensitive to perceived palatability of the food, hunger, sensory-specific factors, cultural and social cues, participant stress level and sleeping habits (Brunstrom, Brown, Hinton, Rogers, & Fay, 2011; Hetherington, 2007; Lemmens, Rutter, Born, & Westerterp-Plantenga, 2001 ; Morselli, Leproult, Balbo, & Spiegal, 2010) among other inputs. The contribution of these factors to the overall satiety response in VAS is therefore difficult to control and predict at the individual level. However, all participants of our studies were exposed to the same novelty of the environment by having the healthy volunteers testing in a clinical pharmacology/metabolic research facility and by monitoring food intake. In addition, the vast majority (95%) of the participants consumed all of the food in 3 daily meals designed to match their REE, as proposed by protocol.
Previous research has indicated that increasing total fiber intake can help to reduce energy intake by decreasing hunger and/or increasing fullness (Howarth et al. 2001; Venn & Mann, 2004) . There are several mechanisms by which different dietary fibers may influence hunger and food intake. Gastric distension and food energy replacement by a bulking effect are common mechanisms of dietary fibers associated more with satiation than inter-meal satiety (Blackwood, Salter, Dettmar, & Chaplin, 2000; Wanders et al. 2013) . However, the ingestion of fiber may suppress energy intake by inducing satiation and satiety (Blundell & Burley, 1987) .
Dietary fiber affects satiety in many ways, depending on the fiber type, and relating to its ability to bulk foods, increase viscosity, gel in the stomach and ferment in the gut (Slavin & Green, 2007) . Psyllium is a soluble viscous fiber that has the ability to gel in the stomach. Both aspects are important for the efficacy of psyllium. McRorie (2015) has extensively reviewed this issue and suggested that the gel-forming fibers (such as psyllium) may influence satiety by several mechanisms, including delayed degradation and absorption of nutrients in the small bowel, leading to a 'sustained' delivery of nutrients; and delivery of nutrients to the distal ileum with subsequent stimulation of feedback mechanisms like the 'ileal brake' phenomenon (slows gastric emptying and small bowel transit) and decreased appetite. These proposed mechanisms involve the participation of gut hormones and the central nervous system favoring higher sensations of satiety (De Graaf et al., 2004; Howarth et al. 2001) . Supporting this hypothesis, others demonstrated that gel-forming fibers increase satiety and reduce subsequent energy intake (Archer, Johnson, Devereux, & Baxter, 2004; Di Lorenzo, Williams, Hajnal, & Valenzuela, 1988; Tiwary, Ward, & Jackson, 1997; Wanders, Mars, Borgonjen-van den Berg, De Graaf, & Feskens, 2014) .
In our 2 studies, no biomarkers were collected that would permit assessment of the correlations with the measured satiety responses. The intention of these 2 studies was to demonstrate that psyllium supplementation at acceptable and well tolerated doses can affect significantly the inter-meal satiety response. In addition, previous work on satiety biomarkers suggested that presently available biomarkers are not sufficiently sensitive to reflect satiety sensations or predict food intake in clinical trials (De Graaf et al., 2004) .
There have been a limited number of placebo-controlled, randomized trials investigating the effect of psyllium fiber on satiety. Bergmann et al. (1992) studied the effects of 10.8 g of psyllium or placebo on the gastric emptying and satiety of 12 healthy volunteers consuming a standard meal. Psyllium increased the sensation of fullness and decreased hunger at the sixth hour after the meal compared to placebo. The correlation between gastric emptying and visual analog scale responses for hunger was significant in their study. Rigaud et al. (1998) tested the effect of oral administration of 7.4 g of psyllium on the gastric emptying and satiety of 14 healthy volunteers in a low energy diet in a placebo-controlled study. After the meal, hunger feelings and energy intake were significantly lower during the psyllium than during the placebo treatments. However, these investigators did not find significant psyllium mediated alterations of gastric emptying in their study. The magnitude of the satiating effects of psyllium in these studies was similar to the range observed in our studies. Other investigations with psyllium also showed some degree of efficacy on satiety (Delargy et al. 1997; Hylander & Rӧssner 1983; Salas-Salvado et al. 2008; Turnbull & Thomas, 1995) but were methodologically different (open label, active comparators, different form or mixed composition of fibers) hampering comparisons with our findings. In addition, the magnitude of the satiety effect observed in our studies with psyllium fiber was similar to the effect observed by others with oatmeal in a more recent comparative study with ready-to eat cereal (Rebello et al. 2013) . Similar to our interpretation, the authors attributed the differences in satiety to the viscosity and hydration properties of the b-glucan content of oatmeal.
The most commonly reported AEs in these studies were gastrointestinal symptoms. Initial gastrointestinal AEs are common with start of fiber intake and are noted in published reports (Oliver, 2000) . Nevertheless, all reported AEs were mild or moderate and did not interfere with subject participation or affect the consumption of the meals. The total number of subjects having AEs with the 3.4 g and 6.8 g twice a day doses were not different than placebo in these studies suggesting that the these doses would be more appropriate for satiety effects without confounding abdominal sensations.
In conclusion, the 2 studies included in this report confirm that psyllium supplementation before meals is well tolerated and can significantly affect satiety by decreasing hunger, increasing fullness, and reducing the desire to eat between meals. 
